当前位置：
X-MOL 学术
›
Poul. Sci.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Assessing the efficacy of a recombinant H9N2 avian influenza virus-inactivated vaccine.
Poultry Science ( IF 3.8 ) Pub Date : 2020-06-24 , DOI: 10.1016/j.psj.2020.06.012 Cai Liang Song 1 , Zhi Hong Liao 1 , Yong Shen 1 , Huang Wang 1 , Wen Cheng Lin 2 , Hongxin Li 2 , Wei Guo Chen 2 , Qing Mei Xie 2
Poultry Science ( IF 3.8 ) Pub Date : 2020-06-24 , DOI: 10.1016/j.psj.2020.06.012 Cai Liang Song 1 , Zhi Hong Liao 1 , Yong Shen 1 , Huang Wang 1 , Wen Cheng Lin 2 , Hongxin Li 2 , Wei Guo Chen 2 , Qing Mei Xie 2
Affiliation
The H9N2 avian influenza virus has been widely spread in poultry around the world. It is proved to the world that the avian influenza virus can directly infect human beings without any intermediate host adaptation in "1997 Hong Kong avian influenza case," which shows that the avian influenza virus not only causes significant losses to the poultry industry but also affects human health. In this study, we aimed to address the problem of low protection of avian H9N2 subtype influenza virus vaccine against H9N2 wild-type virus. We have rescued the H9.4.2.5 branched avian influenza virus isolated in South China by reverse genetics technology. We have recombined these virus (rHA/NA-GD37 and rHA/NA-GD38) which contain hemagglutinin and neuraminidase genes from the H9N2 avian influenza virus (MN064850 or MN064851) and 6 internal genes from the avian influenza virus (KY785906). We compared the biological properties of the virus for example virus proliferation, virus elution, thermostability, and pH stability. Then, we evaluated the immune effects between rHA/NA-GD37 and GD37, which show that the recombinant avian influenza virus-inactivated vaccine can stimulate chickens to produce higher antibody titers and produce little inflammatory response after the challenge. It is noticeable that the recombinant virus-inactivated vaccine had better immune impact than the wild-type inactivated vaccine. Generally speaking, this study provides a new virus strain for the development of a H9N2 vaccine.
更新日期：2020-06-24
京公网安备 11010802027423号